Minocycline Accord-Uk (Minocycline)

• Minocycline is a broad‑spectrum tetracycline antibiotic used to manage several bacterial infection categories.
• Acne vulgaris: reduces inflammatory lesions and bacterial colonisation on the skin.
• Respiratory tract infections: treats community‑acquired pneumonia and bronchitis caused by susceptible organisms.
• Urinary tract infections: eradicates common uropathogens in uncomplicated cases.
• Skin and soft‑tissue infections: combats cellulitis, abscesses and wound infections.
• Rickettsial infections: effective against diseases such as Rocky Mountain spotted fever.

• Minocycline inhibits bacterial protein synthesis by binding to the 30S ribosomal subunit, blocking the attachment of aminoacyl‑tRNA. This action prevents elongation of the nascent peptide chain, halting bacterial growth and leading to a bacteriostatic effect against susceptible Gram‑positive and Gram‑negative organisms.

Common Side Effects

• Nausea or vomiting: mild gastrointestinal upset.
• Diarrhea: loose stools that may be self‑limiting.
• Photosensitivity: increased skin reaction to sunlight.
• Dizziness or vertigo: transient balance disturbances.
• Skin discoloration: hyperpigmentation of the skin or nails.
• Taste alteration: metallic or bitter taste sensation.

Serious or Rare Side Effects

• Drug‑induced lupus erythematosus: systemic autoimmune reaction.
• Stevens‑Johnson syndrome or toxic epidermal necrolysis: severe skin blistering.
• Hepatic toxicity: elevated liver enzymes or hepatitis.
• Intracranial hypertension: headache, visual changes, papilledema.
• Anaphylaxis: acute allergic reaction with airway compromise.
• Severe vestibular toxicity: persistent vertigo and ataxia.

• Before initiating therapy, consider the following safety measures.
• Assess renal function: adjust dose in patients with impaired clearance.
• Monitor liver enzymes: watch for signs of hepatic injury.
• Avoid use in children under 8 years: risk of permanent tooth discoloration.
• Limit sun exposure: use protective clothing and sunscreen.
• Review concomitant medications: evaluate for potential interactions.
• Store at ambient temperature: keep in the original container, protect from moisture and heat.

Minocycline may interact with several drug classes, requiring attention to avoid reduced efficacy or increased toxicity.

Major Interactions (Avoid)

• Antacids containing aluminum or magnesium: decrease absorption of minocycline.
• Iron supplements: chelate the drug and reduce bioavailability.
• Warfarin: may potentiate anticoagulant effect and raise INR.
• Oral contraceptives: may reduce hormonal efficacy, increasing pregnancy risk.
• Retinoids: combined use can raise intracranial pressure.

Moderate Interactions (Monitor Closely)

• Cyclosporine: may increase nephrotoxicity.
• Digoxin: potential for altered serum levels.
• Phenytoin: may enhance hepatic enzyme induction, lowering minocycline levels.
• Macrolide antibiotics: additive risk of hepatotoxicity.
• Vitamin D analogues: monitor calcium balance.